膀胱癌多参数磁共振成像:VI-RADS(膀胱影像报告与数据系统)的制定
该文通过共识方法制定膀胱癌mpMRI的标准化成像与报告系统VI-RADS。基于T2加权、弥散加权和动态对比增强提出五点评分,提示肌层浸润风险。VI-RADS旨在规范报告、便于患者间比较,未来将接受验证和优化。
要点
- VI-RADS基于T2加权、弥散加权和动态对比增强制定五点评分。
- 该评分用于提示膀胱癌肌层浸润风险。
- 标准化报告包括肿瘤大小、位置、多发性和形态。
核心结论
- VI-RADS通过共识制定,旨在标准化膀胱mpMRI的成像与报告,便于患者间比较,未来将接受验证和优化。
研究设计与样本
- 通过共识方法,基于现有文献制定VI-RADS。
主要发现
- 描述了膀胱mpMRI的标准成像方案和报告标准,包括大小、位置、多发性和形态。
- 提出了基于T2加权MRI、弥散加权成像和动态对比增强的五点VI-RADS评分,提示肌层浸润风险。
- 提供了用于理解VI-RADS的示例图像。
关键数值与推荐
- VI-RADS为五点评分,基于T2加权MRI、弥散加权成像和动态对比增强,提示肌层浸润风险。
临床怎么用
- VI-RADS可标准化报告、促进患者间比较,并可能补充病理或减少基于辐射的成像。
- 膀胱mpMRI可能最适用于非肌层浸润性癌症患者,以加速根治性治疗或确定保留膀胱治疗的反应。
- 不主张对所有膀胱癌患者进行mpMRI。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Management of bladder cancer (BC) is primarily driven by stage, grade, and biological potential. Knowledge of each is derived using clinical, histopathological, and radiological investigations. This multimodal approach reduces the risk of error from one particular test, but may present a staging dilemma when results conflict. Multiparametric magnetic resonance imaging (mpMRI) may improve patient care through imaging of the bladder with better resolution of the tissue planes than computed tomography and without radiation exposure. OBJECTIVE: To define a standardized approach to imaging and reporting mpMRI for BC, by developing a VI-RADS score. EVIDENCE ACQUISITION: We created VI-RADS (Vesical Imaging-Reporting And Data System) through consensus using existing literature. EVIDENCE SYNTHESIS: We describe standard imaging protocols and reporting criteria (including size, location, multiplicity, and morphology) for bladder mpMRI. We propose a five-point VI-RADS score, derived using T2-weighted MRI, diffusion-weighted imaging, and dynamic contrast enhancement, which suggests the risks of muscle invasion. We include sample images used to understand VI-RADS. CONCLUSIONS: We hope that VI-RADS will standardize reporting, facilitate comparisons between patients, and in future years, will be tested and refined if necessary. While we do not advocate mpMRI for all patients with BC, this imaging may compliment pathology or reduce radiation-based imaging. Bladder mpMRI may be most useful in patients with non-muscle-invasive cancers, in expediting radical treatment or for determining response to bladder-sparing approaches. PATIENT SUMMARY: Magnetic resonance imaging (MRI) scans for bladder cancer are becoming more common and may provide accurate information that helps improve patient care. Here, we describe a standardized reporting criterion for bladder MRI. This should improve communication between doctors and allow better comparisons between patients.
引用
- Panebianco V, Narumi Y, Altun E, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol. 2018. PMID: 29755006. doi:10.1016/j.eururo.2018.04.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。